A Clinical Study of Enlicitide Decanoate in People With Liver Function Problems (MK-0616-030)

NCT06575959 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Insufficiency
Hepatic Impairment

Interventions

DRUG: Enlicitide

Sponsor

Merck Sharp & Dohme LLC